Bioptamers - Crunchbase Company Profile & Funding

Q: Who invested in Bioptamers?

Bioptamers has 2 investors including RebelBio And SOSV.

Q: When was the last funding round for Bioptamers?

Bioptamers closed its last funding round on obfuscated from a Seed round.

Overview

Bioptamers

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Bioptamers

CB Rank

300897

Personalized Precision Therapies

Founded

obfuscation

Private

Seed

New Castle, Delaware, United States

1-10

bioptamers.com

Biotechnology

Health Care

Life Science

Pharmaceutical

Funding Rounds

Seed

OBF

obfuscation

Key People

Erika Molina: Founder & CEO
Emerson Moretto: Co-Founder

Details

Legal Name

Bioptamers Inc.

Operating Status

Active

Company Type

For Profit

Founders

Emerson Moretto, Erika Molina

About the Company

We are developing a platform to optimise the aptamer selection to personalise cancer therapy matching the specific patient needs. Our development process will convert those molecules into valuable clinical products to license for pharmaceutical companies.

Contact Email

erika@bioptamers.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Personalized Aptamer-Based Therapeutics

Synthetic molecules designed to specifically identify cancer cells and deliver targeted therapeutic interventions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Bioptamers	2	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
RebelBio	—	Seed Round - Bioptamers	—
RebelBio	—	Seed Round - Bioptamers	—
RebelBio	—	Seed Round - Bioptamers	—
RebelBio	—	Seed Round - Bioptamers	—
RebelBio	—	Seed Round - Bioptamers	—